Unijules Life Sciences UNIJULES Life Sciences
Staff Login
Pharmacovigilance & Drug Safety

From Farm to Pharma

Unijules Life Sciences Ltd manufactures and markets allopathic, herbal, and nutraceutical formulations — aiming to make high-quality healthcare affordable for the common man. If you or someone you know has experienced a suspected side effect from one of our products, please tell us about it below.

Our Company

Affordable healthcare, backed by research

We believe pharmaceutical innovation should reach the common man at an affordable cost, not just the affluent. Our teams work across allopathic, herbal, and nutraceutical formulation, pairing research and development with WHO-GMP certified manufacturing, so that new drug delivery advances reach the market faster and more reliably.

Research & Innovation

A dedicated R&D wing, including proprietary pellet-based herbal delivery technology and ongoing formulation development.

Complex Formulations

Expertise spanning capsules, tablets, injectables, liquids, semisolids and powders across allopathic and herbal product lines.

Certified Manufacturing

WHO-GMP certified facilities with an in-house quality-control and microbiology laboratory, staffed by experienced QA technocrats.

What We Make

Product portfolio

Allopathic Products

Critical care, anti-infective, gastrointestinal, anti-allergic and cough preparations.

Herbal Products

Ayurvedic and herbal formulations, including our pellet-based Herbules delivery technology.

Nutraceutical Products

Nutritional and dietary supplement formulations for everyday health support.

Contrast Media Products

Diagnostic imaging contrast agents for radiology use.

Large Volume Parenterals

Sterile large-volume infusion products for hospital and institutional use.

Small Volume Parenterals

Sterile injectable formulations in small-volume presentations.

Bulk DC Granules

Directly-compressible bulk granules supplied for further pharmaceutical manufacture.

Our Pharmacovigilance Drug Safety Cell

Unijules maintains a dedicated Drug Safety Cell to receive, review, and investigate reports of suspected adverse reactions to our products — including a cell specifically covering our injectable product line. Every report submitted here is reviewed by our safety team; serious reports are prioritized and followed up according to regulatory timelines.

Report an Adverse Event Now
Registered Office
B-35 & 36, MIDC Industrial Area,
Kalmeshwar, Dist. Nagpur – 441501
Maharashtra, India
Drug Safety Cell — Injectable Products
D-82, MIDC Area, Cross Road No. 4A,
Hingna, Nagpur – 440028
Maharashtra, India